newsfilter
← Latest News
PR Newswire·

Number of shares and votes in BioArctic AB (publ) as of August 31, 2026

BIOA
  • BioArctic AB issued 20,200 Class B shares in August 2026 for delivery to participants in the 2019/2028 stock option program.
  • The share issuance resulted from the exercise of 20,200 stock options under the 2019/2028 series.
  • As of August 31, 2026, BioArctic's total share count reached 88,744,685, comprising 74,344,689 listed Class B shares with one vote each.
  • The company held 14,399,996 unlisted Class A shares, each carrying ten votes, resulting in a total of 218,344,649 votes.
  • BioArctic AB is a Swedish biopharma company developing treatments for neurodegenerative diseases, including Leqembi® for Alzheimer's disease developed with Eisai.
  • The company's research portfolio includes antibodies for Parkinson's disease, ALS, Alzheimer's disease, \& projects utilizing the proprietary BrainTransporter™ technology.
  • BioArctic's Class B shares are listed on Nasdaq Stockholm Large Cap, \& the disclosed share \& vote data was released on August 31, 2026, at 5:30pm CEST.